Renee Minjarez, MD
Vascular Surgery · Bellevue, WANPI 1639373277
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,871 of the $5,869 with a category attached, or 66.0%. It is spread thinly across 23 manufacturers, the largest accounting for just 22.4%. 2025 is the largest year on record at $2,871, more than ten times the $242 reported in 2019.
Across 84 payments — averaging $69.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Silk Road Medical, Inc.$1K
- Centinel Spine, LLC$1K
- Endologix LLC$764
- Medtronic$672
- Inari Medical, Inc.$453
- Shockwave Medical, Inc$447
- plus $1K from 17 others
Across 4 payments — averaging $12,058 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bard Peripheral Vascular, Inc.$48K
What the payments were for
- Travel & lodging$1,99734%
- Food & beverage$3,87166%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Silk Road Medical, Inc. | 9 | $1,313 |
| Centinel Spine, LLC | 4 | $1,003 |
| Endologix LLC | 6 | $764 |
| Medtronic(2 entities) | 15 | $672 |
| Inari Medical, Inc. | 7 | $453 |
| Shockwave Medical, Inc | 7 | $447 |
| Boston Scientific | 6 | $166 |
| Cook Medical LLC | 6 | $161 |
| Penumbra, Inc. | 1 | $140 |
| Vertex | 1 | $119 |
| Philips North America LLC | 2 | $88 |
| Cardiovascular Systems Inc. | 1 | $88 |
| Johnson & Johnson | 3 | $75 |
| W. L. Gore & Associates, Inc. | 4 | $67 |
| Bolton Medical Inc | 1 | $62 |
| Globus Medical | 2 | $53 |
| Terumo Medical Corporation | 2 | $49 |
| Pfizer | 2 | $45 |
| Abbott | 1 | $30 |
| KCI USA, Inc. | 1 | $22 |
| Argon Medical Devices, Inc. | 1 | $18 |
| Bard Peripheral Vascular, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Stent$1,100
- ENHANCE Transcarotid Peripheral Access Kit$1,100
- ENROUTE Transcarotid Neuroprotection System$1,100
- ENROUTE .014 Guidewire$1,100
- PRODISC L$964
- Torus Stent Graft System$602
- ENDOCROSS Device$602
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$370
- FLOWTRIEVER CATHETER, S$214
- Indigo System$140
- JOURNAVX$119
- ENDURANT IIS$117
- VenaSeal$117
How this compares
$5,869 in reported general payments places this provider in the 55th percentile of 111 vascular surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 167 | $181,581 |
| EliquisApixaban | 70 | $78,275 |
| Atorvastatin Calcium | 89 | $868 |
| Cilostazol | 21 | $853 |
| ClopidogrelClopidogrel Bisulfate | 48 | $404 |
| Rosuvastatin Calcium | 48 | $324 |
| Ezetimibe | 16 | $169 |
| Triamcinolone Acetonide | 16 | $79 |
| Cephalexin | 23 | $25 |
| Warfarin Sodium | 11 | $12 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $75 | $181,581167 claims |
| PfizerEliquis | $45 | $78,27570 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 111 vascular surgery providers in Washington.
Other vascular surgery in Bellevue
- Kathleen GibsonBellevue$593K
- Brian FerrisBellevue$170K
- Mark OmbrellaroBellevue$12K
- Elica InagakiBellevue$10K
- Sooyeon KimBellevue$9K
- Benjamin StarnesSeatle$666K
- Sara ZettervallSeattle$126K
- Paul HayesSeattle$83K
- Elina QuirogaSeattle$69K
- Lorena de Marco GarciaYakima$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.